Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

5 reasons why mobile technology needs clinical trials

David Lee Scher, MD
Tech
February 6, 2013
Share
Tweet
Share

shutterstock_103546670

I have long been a proponent of proven technology in the digital health space.  Probably the most obvious reason is to dispel the generalized notion that these technologies are flimsy.  The HHS Text4HealthTask Force has endorsed clinical studies in its recommendations. There certainly have been studies performed. One interesting one, the final report of The National Mobile Health Worker Project of the Department of Health of the UK documents improved efficiencies in the healthcare system.

Another study by the Geisinger Health System demonstrated in a randomized trial of 875 post-discharge patients, that readmission rates were decreased 44% with remote patient monitoring.  However, there are others which have other findings. One example is a study evaluating the effectiveness of bed alarms of 27,672 patients in 16 nursing units of an urban hospital.  The study showed no significant effect of bed alarms on the incidence of fall-related events or physical restraint use.

In addition, a systematic review and meta analysis of all mobile health technology studies evaluating healthcare delivery processes revealed, “…Trials using mobile technology-based photos reported reductions in correct diagnoses when compared to the gold standard. SMS appointment reminders have modest benefits and may be appropriate for implementation. High quality trials measuring clinical outcomes are needed …”

I would like to give my own reasons why efficacy studies are needed.

1. It’s about health, not technology.  Digital health technologies are being discussed because there are operational, economic, and clinical problems to be solved. The former two affect the latter. If a technology isn’t ultimately going to benefit the patient with a better outcome at a reasonable (and most cases cheaper) cost, it will not be paid for.  This has been the dictum of Medicare in the recent past, and is certainly logical from the standpoint of an outcomes-based reimbursement perspective which will be the new norm. Tech companies need to have the patient (and more specifically) a problem to solve as the reason for development. Nothing else will succeed.  The only way to demonstrate problem solving is with studies.

2. Even these technologies need to demonstrate an ROI. The importance of clinical efficacy trials from a business perspective is to be able to make a claim (I predict the FTC will be cracking down more in the sector in the future) and for competitive market positioning. This ultimately boils down to being able to estimate or calculate an ROI.

3. The need to spur investing in the sector. Investment in digital health technologies, specifically mobile health technologies has been in the consumer realm.  This is because of the younger more tech-savvy users of wellness-focused technology and the lack of required review by regulators. However, the real need for devices like remote patient monitoring to impact chronic disease states utilizing most of healthcare resources requires investing which is lacking.  The biggest potential cost-savings (and likely lucrative) technologies require the most investing. But investors are shy because of the lack of efficacy studies. Can one blame them?

4. Instill confidence in all users. Users of these technologies will be healthcare providers at all levels, IT personnel, patients, payers, Pharma and medical device companies, in essence, all stakeholders in healthcare. Credibility of these technologies needs to be established by the way in which they are used to: efficacy trials.  This is not to say that trials need to be all randomized control traditional trials. Crowdsourced and smaller studies can work.  They just need to be designed properly and hopefully be comparative, not like traditional pharmaceutical and device trials. In addition, the data must be open and not proprietary. This sector needs to be open sourced in all respects.

5. Studies need to be done to establish competitive market shares. These technologies lend themselves to comparative outcomes research because the data is so readily available and there will be so many ‘me too’ products out there.  Hospitals and other providers will be scrambling for these products to meet mandates and to decrease cost. Having a few minutes with a C-suite crew will be much easier if the ‘show me the money’ data is right there. Let the studies speak for themselves, instead of the whole industry getting written off as flimsy and unproven.

David Lee Scher is a former cardiologist and a consultant at DLS Healthcare Consulting, LLC.  He blogs at his self-titled site, David Lee Scher, MD.

Image credit: Shutterstock.com

Prev

Clostridium difficile: A fecal transplant when all else fails

February 6, 2013 Kevin 4
…
Next

Answers to common vaccine questions from patients

February 6, 2013 Kevin 3
…

Tagged as: Health IT

Post navigation

< Previous Post
Clostridium difficile: A fecal transplant when all else fails
Next Post >
Answers to common vaccine questions from patients

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

More by David Lee Scher, MD

  • 5 things digital health companies need to do to achieve success

    David Lee Scher, MD
  • Want a successful digital health initiative? These 5 things need to happen first.

    David Lee Scher, MD
  • a desk with keyboard and ipad with the kevinmd logo

    How mobile technology can improve clinical trials

    David Lee Scher, MD

More in Tech

  • How Mark Twain would dismantle today’s flawed medical AI

    Neil Baum, MD and Mark Ibsen, MD
  • 9 domains that will define the future of medical education

    Harvey Castro, MD, MBA
  • Key strategies for smooth EHR transitions in health care

    Sandra Johnson
  • Why flashy AI tools won’t fix health care without real infrastructure

    David Carmouche, MD
  • Why innovation in health care starts with bold thinking

    Miguel Villagra, MD
  • How self-improving AI systems are redefining intelligence and what it means for health care

    Harvey Castro, MD, MBA
  • Most Popular

  • Past Week

    • Why flashy AI tools won’t fix health care without real infrastructure

      David Carmouche, MD | Tech
    • Key strategies for smooth EHR transitions in health care

      Sandra Johnson | Tech
    • 2 hours to decide my future: How the SOAP residency match traps future doctors

      Nicolette V. S. Sewall, MD, MPH | Education
    • Reassessing the impact of CDC’s opioid guidelines on chronic pain care [PODCAST]

      The Podcast by KevinMD | Podcast
    • When the diagnosis is personal: What my mother’s Alzheimer’s taught me about healing

      Pearl Jones, MD | Conditions
    • Why Medicaid cuts should alarm every doctor

      Ilan Shapiro, MD | Policy
  • Past 6 Months

    • Why tracking cognitive load could save doctors and patients

      Hiba Fatima Hamid | Education
    • What the world must learn from the life and death of Hind Rajab

      Saba Qaiser, RN | Conditions
    • How scales of justice saved a doctor-patient relationship

      Neil Baum, MD | Physician
    • The silent toll of ICE raids on U.S. patient care

      Carlin Lockwood | Policy
    • My journey from misdiagnosis to living fully with APBD

      Jeff Cooper | Conditions
    • “Think twice, heal once”: Why medical decision-making needs a second opinion from your slower brain (and AI)

      Harvey Castro, MD, MBA | Tech
  • Recent Posts

    • Why removing fluoride from water is a public health disaster

      Steven J. Katz, DDS | Conditions
    • What the research really says about infrared saunas

      Khushali Jhaveri, MD | Conditions
    • How the cycle of rage is affecting physicians—and how to break free

      Alexandra M.P. Brito, MD and Jennifer L. Hartwell, MD | Conditions
    • Why ADHD in adults is often missed—and why it matters [PODCAST]

      The Podcast by KevinMD | Podcast
    • Dedicated hypermobility clinics can transform patient care

      Katharina Schwan, MPH | Conditions
    • It’s time for pain protocols to catch up with the opioid crisis

      Sarah White, APRN | Conditions

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 3 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • Why flashy AI tools won’t fix health care without real infrastructure

      David Carmouche, MD | Tech
    • Key strategies for smooth EHR transitions in health care

      Sandra Johnson | Tech
    • 2 hours to decide my future: How the SOAP residency match traps future doctors

      Nicolette V. S. Sewall, MD, MPH | Education
    • Reassessing the impact of CDC’s opioid guidelines on chronic pain care [PODCAST]

      The Podcast by KevinMD | Podcast
    • When the diagnosis is personal: What my mother’s Alzheimer’s taught me about healing

      Pearl Jones, MD | Conditions
    • Why Medicaid cuts should alarm every doctor

      Ilan Shapiro, MD | Policy
  • Past 6 Months

    • Why tracking cognitive load could save doctors and patients

      Hiba Fatima Hamid | Education
    • What the world must learn from the life and death of Hind Rajab

      Saba Qaiser, RN | Conditions
    • How scales of justice saved a doctor-patient relationship

      Neil Baum, MD | Physician
    • The silent toll of ICE raids on U.S. patient care

      Carlin Lockwood | Policy
    • My journey from misdiagnosis to living fully with APBD

      Jeff Cooper | Conditions
    • “Think twice, heal once”: Why medical decision-making needs a second opinion from your slower brain (and AI)

      Harvey Castro, MD, MBA | Tech
  • Recent Posts

    • Why removing fluoride from water is a public health disaster

      Steven J. Katz, DDS | Conditions
    • What the research really says about infrared saunas

      Khushali Jhaveri, MD | Conditions
    • How the cycle of rage is affecting physicians—and how to break free

      Alexandra M.P. Brito, MD and Jennifer L. Hartwell, MD | Conditions
    • Why ADHD in adults is often missed—and why it matters [PODCAST]

      The Podcast by KevinMD | Podcast
    • Dedicated hypermobility clinics can transform patient care

      Katharina Schwan, MPH | Conditions
    • It’s time for pain protocols to catch up with the opioid crisis

      Sarah White, APRN | Conditions

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

5 reasons why mobile technology needs clinical trials
3 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...